Review
Version 1
Preserved in Portico This version is not peer-reviewed
CSWS [Continuous Spike-Waves During Slow-Sleep] Today: An Update
Version 1
: Received: 21 December 2023 / Approved: 22 December 2023 / Online: 22 December 2023 (07:52:24 CET)
A peer-reviewed article of this Preprint also exists.
Posar, A.; Visconti, P. Continuous Spike–Waves during Slow Sleep Today: An Update. Children 2024, 11, 169. Posar, A.; Visconti, P. Continuous Spike–Waves during Slow Sleep Today: An Update. Children 2024, 11, 169.
Abstract
In the contest of childhood epilepsies, the concept of continuous spike-waves during slow sleep (CSWS) includes several childhood-onset heterogeneous conditions, sharing an electroencephalogram (EEG) characterized by a high frequency of paroxysmal abnormalities during sleep which are attributed negative effects on the cognitive development and behavior of the child. These negative effects may have the characteristics of a clear regression or of a slowdown in development. Seizures are very often present, but not constantly. The above makes it clear why CSWS have been included in epileptic encephalopathies, in which by definition the frequent EEG paroxysmal abnormalities have an unfavorable impact on the cognitive functions, including socio-communicative skills causing autistic features, even regardless of the presence of clinically overt seizures. Although several decades have passed since the original descriptions of the electroclinical condition of CSWS, there are still many areas that are little known and deserve to be further studied, including the EEG diagnostic criteria, the most effective electrophysiological parameter for monitoring the evolution, the role of the thalamus in the CSWS pathogenesis, the long-term evolution, the nosographic location of Landau-Kleffner syndrome, the standardized neuropsychological and behavioral assessment, the pharmacological and non-pharmacological therapies.
Keywords
epilepsy; epileptic encephalopathies; CSWS; ESES; Landau-Kleffner syndrome
Subject
Medicine and Pharmacology, Neuroscience and Neurology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment